Predict your next investment

Corporation
HEALTHCARE | Biotechnology
ferring.com

See what CB Insights has to offer

Investments

2

Partners & Customers

10

About Ferring Pharmaceuticals

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group. Ferring Pharmaceuticals specializes in the areas of reproductive medicine and women’s health, urology and gastroenterology.

Ferring Pharmaceuticals Headquarter Location

Chemin de la Vergognausaz 50

Saint-Prex, 1162,

Switzerland

+41 (0)58 301 00 00

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Ferring Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Ferring Pharmaceuticals in 2 Expert Collections, including Medical Devices.

M

Medical Devices

295 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

W

Women's Health & Wellness

1,458 items

Startups focused on providing products and services catering to women's health and wellbeing.

Ferring Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Ferring Pharmaceuticals Rank

Research containing Ferring Pharmaceuticals

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Ferring Pharmaceuticals in 1 CB Insights research brief, most recently on Nov 27, 2019.

Latest Ferring Pharmaceuticals News

Worldwide Human Microbiome Industry to 2028 - by Indication, Therapeutics Area and Region - ResearchAndMarkets.com

May 12, 2022

Ferring Pharmaceuticals The report provides revenue of the global human microbiome market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global human microbiome market during the forecast period. The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global human microbiome market. Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global human microbiome market. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global human microbiome market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global human microbiome market. The report delves into the competition landscape of the global human microbiome market. Key players operating in the global human microbiome market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global human microbiome market that have been profiled in this report. Key Questions Answered in Human Microbiome Market Report What is the scope of growth of human microbiome diagnostics & therapeutics in the global human microbiome market? What will be the Y-o-Y growth of the global human microbiome market between 2021 and 2028? What is the influence of changing trends in technologies on the global human microbiome market? Which region will continue to be the most profitable market for human microbiome? Which factors are anticipated to hamper the growth of the global human microbiome market during the forecast period? Which are the leading companies in the global human microbiome market? Key Topics Covered: 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.2. Microbiome Therapeutics Pipeline Scenario 5.3. Regulatory Scenario across globe 5.4. Impact of human microbiome therapeutics on current treatment options 5.5. Key Mergers & Acquisitions 7. Global Human Microbiome Market Analysis and Forecast, by Therapeutic Area 8. Global Human Microbiome Market Analysis and Forecast, by Region 9. North America Human Microbiome Market Analysis and Forecast 10. Europe Human Microbiome Market Analysis and Forecast 11. Asia Pacific Human Microbiome Market Analysis and Forecast 12. Latin America Human Microbiome Market Analysis and Forecast 13. Middle East & Africa Human Microbiome Market Analysis and Forecast 14. Competition Landscape 14.2. Market Share / Position Analysis, by Company, 2020 14.3. Company Profiles Contacts

Ferring Pharmaceuticals Investments

2 Investments

Ferring Pharmaceuticals has made 2 investments. Their latest investment was in Robyn as part of their Corporate Minority on February 2, 2022.

CBI Logo

Ferring Pharmaceuticals Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/15/2022

Corporate Minority

Robyn

Yes

1

11/25/2019

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/15/2022

11/25/2019

Round

Corporate Minority

Corporate Minority

Company

Robyn

Subscribe to see more

Amount

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

1

10

Ferring Pharmaceuticals Acquisitions

3 Acquisitions

Ferring Pharmaceuticals acquired 3 companies. Their latest acquisition was Rebiotix on April 05, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/5/2018

Convertible Note

$99M

$38.52M

Acquired

3

10/10/2017

Subscribe to see more

$99M

Subscribe to see more

10

2/19/2015

Series D

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

4/5/2018

10/10/2017

2/19/2015

Investment Stage

Convertible Note

Series D

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

$38.52M

$99M

Note

Acquired

Subscribe to see more

Subscribe to see more

Sources

3

10

10

Ferring Pharmaceuticals Partners & Customers

10 Partners and customers

Ferring Pharmaceuticals has 10 strategic partners and customers. Ferring Pharmaceuticals recently partnered with Virtamed on February 2, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

2/15/2022

Partner

Switzerland

VirtaMed and Ferring Pharmaceuticals Accelerate First-of-its-kind Global Training Program to Increase Confidence in Embryo Transfers

ZURICH -- -- VirtaMed has announced a partnership with Ferring Pharmaceuticals to expand global access to simulation training for embryo transfers .

1

2/15/2022

Partner

Switzerland

VirtaMed :: VirtaMed and Ferring Pharmaceuticals Accelerate First-of-its-kind Global Training Program to Increase Confidence in Embryo Transfers

Zurich , Switzerland -- VirtaMed has announced a partnership with Ferring Pharmaceuticals to expand global access to simulation training for embryo transfers .

1

11/25/2021

Partner

Finland

University of Eastern Finland and Ferring Ventures to continue collaboration in gene and cell therapy research

`` Ferring Ventures values the long collaboration with University of Eastern Finland .

1

9/20/2021

Partner

China

Subscribe to see more

Subscribe to see more

10

5/19/2021

Partner

Israel

Subscribe to see more

Subscribe to see more

10

Date

2/15/2022

2/15/2022

11/25/2021

9/20/2021

5/19/2021

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

Country

Switzerland

Switzerland

Finland

China

Israel

News Snippet

VirtaMed and Ferring Pharmaceuticals Accelerate First-of-its-kind Global Training Program to Increase Confidence in Embryo Transfers

ZURICH -- -- VirtaMed has announced a partnership with Ferring Pharmaceuticals to expand global access to simulation training for embryo transfers .

VirtaMed :: VirtaMed and Ferring Pharmaceuticals Accelerate First-of-its-kind Global Training Program to Increase Confidence in Embryo Transfers

Zurich , Switzerland -- VirtaMed has announced a partnership with Ferring Pharmaceuticals to expand global access to simulation training for embryo transfers .

University of Eastern Finland and Ferring Ventures to continue collaboration in gene and cell therapy research

`` Ferring Ventures values the long collaboration with University of Eastern Finland .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

Ferring Pharmaceuticals Team

12 Team Members

Ferring Pharmaceuticals has 12 team members, including former Chief Executive Officer, Robert Haigh.

Name

Work History

Title

Status

Robert Haigh

Chief Executive Officer

Former

Paul Navarre

Chief Executive Officer

Former

Keith James

President, Senior Vice President

Former

Pierre Rivière

President, Senior Vice President

Former

Ravi Tayi MD MPH

Chief Medical Officer

Former

Name

Robert Haigh

Paul Navarre

Keith James

Pierre Rivière

Ravi Tayi MD MPH

Work History

Title

Chief Executive Officer

Chief Executive Officer

President, Senior Vice President

President, Senior Vice President

Chief Medical Officer

Status

Former

Former

Former

Former

Former

You May Also Like

Sumitovant Logo
Sumitovant

Sumitovant is a biopharmaceutical group focused on improving drug development. The company offers a tech-enabled approach to drug discovery, development and commercialization.

Octapharma Logo
Octapharma

Octapharma is a provider of health solutions and human protein manufacturer, developing and producing human proteins from human plasma and human cell lines.

Baxter International Logo
Baxter International

Baxter International (NYSE: BAX) is an American healthcare company that provides a broad portfolio of essential renal and hospital products, including home, acute, and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software, and services. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders, and other chronic and acute medical conditions.

B
Biogen IDEC

Biogen (NASDAQ: BIIB) is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.

Ionis Pharmaceuticals Logo
Ionis Pharmaceuticals

Ionis Pharmaceuticals discovers and develops RNA-targeted therapeutics. The company markets SPINRAZA, an antisense drug for spinal muscular atrophy (SMA) in pediatric and adult patients; and Kynamro an oligonucleotide inhibitor for use in patients with homozygous familial hypercholesterolemia to reduce low density lipoprotein-cholesterol, apolipoprotein B, total cholesterol, and as an adjunct to lipid lowering medications and diet. Its drugs in Phase III development include volanesorsen for the treatment of familial chylomicronemia syndrome and familial partial lipodystrophy; and IONIS-TTRRx, an antisense drug for transthyretin amyloidosis.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.